Le Lézard
Classified in: Covid-19 virus

North America Bioanalytical Testing Services Market Report 2022: Rising Demand for Analytical Testing of Biologics and Biosimilars & Increasing Preference for Outsourcing Driving Growth - ResearchAndMarkets.com


The "North America Bioanalytical Testing Services Market 2021-2031 by Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

The North America bioanalytical testing services market is projected to grow by 8.3% annually in the forecast period and reach $3,232.3 million by 2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach.

In-depth qualitative analyses include identification and investigation of the following aspects:

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country.

Based on Molecule Type, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

Based Application, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

By Test Type, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

By Workflow Process, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

By Therapeutic Area, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

By End User, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.

Selected Key Players:

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

3 Segmentation of North America Market by Molecule Type

4 Segmentation of North America Market by Application

5 Segmentation of North America Market by Test Type

6 Segmentation of North America Market by Workflow Process

7 Segmentation of North America Market by Therapeutic Area

8 Segmentation of North America Market by End User

9 North America Market 2021-2031 by Country

10 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/dfv7yh


These press releases may also interest you

at 18:00
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

at 18:00
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis. The company's dividend is...

at 17:52
Adyton Resources Corporation  ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...

at 16:30
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...



News published on and distributed by: